Cardiac Surgery Clinical Research

Recognizing the need for a specialized approach to clinical research, the U-M Medical School Department of Cardiac Surgery established the REMEDY team in 2021 as a dedicated hub for the implementation and execution of complex clinical trials. REMEDY serves as a vital bridge between clinical faculty and research administration—coordinating studies, streamlining patient enrollment, and managing the collection of data to ensure accuracy and compliance. This collaborative infrastructure allows our surgeons and scientists to focus on innovation, while the REMEDY team provides seamless operational support.

Currently managing over 50 active clinical trials and preparing several more for launch, REMEDY oversees a research portfolio that explores breakthrough treatments across multiple cardiovascular domains. Our clinical investigations span critical areas such as aortic conditions, coronary interventions, heart valve technologies, and ventricular assist devices (VADs). These studies examine medical technologies, novel surgical techniques, and emerging treatment strategies aimed at improving both immediate and long-term patient outcomes. Through partnerships with multidisciplinary teams and leading industry collaborators, our researchers are helping expand treatment options for patients with complex cardiovascular conditions.

Every clinical trial we conduct is thoughtfully structured with one goal in mind—to enhance the quality, safety, and effectiveness of cardiac care. Through methodical, patient-centered studies, we continue to refine surgical approaches, reduce risks, and improve recovery times. Our commitment extends beyond incremental improvements as we are dedicated to pushing the frontiers of medical science, ensuring that each research initiative translates into meaningful, life-changing outcomes for patients. This relentless pursuit of excellence is what keeps our department at the forefront of innovation and pushes the boundaries of what’s possible in cardiac surgery.